SS Innovations International (SSII) Total Current Liabilities (2016 - 2026)
SS Innovations International (SSII) reported Total Current Liabilities of $26.0 million for Q1 2026, up 73.67% on a YoY basis from $15.0 million in Q1 2025, and down 0.75% sequentially from $26.2 million in Q4 2025.
SS Innovations International (SSII) Total Current Liabilities (2016 - 2026) Analysis & Trends
SS Innovations International (SSII) has 11 years of Total Current Liabilities data on file, last reported at $26.0 million in Q1 2026.
- For the quarter ending Q1 2026, Total Current Liabilities rose 73.67% year-over-year to $26.0 million; the trailing twelve-month figure through Mar 2026 stood at $26.0 million (up 73.67% YoY), and the FY2025 full-year result was $26.2 million, up 23.03% from the prior year.
- Total Current Liabilities slipped to $26.0 million in Q1 2026, from $26.2 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $26.2 million in Q4 2025 to a low of $221585.0 in Q2 2022.
- A 5-year average of $12.7 million and a median of $13.0 million in 2024 frame the typical range for Total Current Liabilities.
- Across the five-year window, Total Current Liabilities sank 82.93% in 2022 and surged 3525.46% in 2023, its largest moves.
- Tracing SSII's Total Current Liabilities over 5 years: stood at $7.8 million in 2022, then increased by 9.11% to $8.5 million in 2023, then soared by 151.72% to $21.3 million in 2024, then advanced by 23.03% to $26.2 million in 2025, then decreased by 0.75% to $26.0 million in 2026.
- Business Quant data shows SSII's Total Current Liabilities at $26.0 million in Q1 2026, $26.2 million in Q4 2025, and $21.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 18.38 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 6.32 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 11.66 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 4.57 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 1.41 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.22 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.70 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 8.53 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 1.60 Bn |
| 10 | SS Innovations International | 699.75 Mn | 676.14 Mn | 5.33 Mn | 26.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 26.05 Mn |
| Dec 31, 2025 | 26.24 Mn |
| Sep 30, 2025 | 21.19 Mn |
| Jun 30, 2025 | 19.61 Mn |
| Mar 31, 2025 | 15.00 Mn |
| Dec 31, 2024 | 21.33 Mn |
| Sep 30, 2024 | 18.50 Mn |
| Jun 30, 2024 | 14.98 Mn |
| Mar 31, 2024 | 13.03 Mn |
| Dec 31, 2023 | 8.47 Mn |
| Sep 30, 2023 | 8.50 Mn |
| Jun 30, 2023 | 8.03 Mn |
| Mar 31, 2023 | 5.12 Mn |
| Dec 31, 2022 | 7.77 Mn |
| Sep 30, 2022 | 1.32 Mn |
| Jun 30, 2022 | 221,585.00 |
| Mar 31, 2022 | 278,250.00 |
| Dec 31, 2021 | 287,281.00 |
| Sep 30, 2021 | 1.28 Mn |
| Jun 30, 2021 | 1.30 Mn |